1st Quarter - Report — FARRAGUT PARTNERS LLP for GENENTECH (2016)

Firm

FARRAGUT PARTNERS LLP

Client

GENENTECH

Income

$50,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Monitor Drug Safety and pedigree legislation.

Lobbyist	Covered position, as disclosed
JODY SHINTARO GALE	—
JEFF MACKINNON	LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER	Prof Staff on E&C Cmte and LA Rep Whitfield
JOSEPH V VASAPOLI	Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to the implementation of the followon biologics provisions in P.L. 111148" Patient Protection and Affordable Care Act".

Lobbyist	Covered position, as disclosed
JODY SHINTARO GALE	—
JEFF MACKINNON	LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER	Prof Staff on E&C Cmte and LA Rep Whitfield
JOSEPH V VASAPOLI	Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Concerns regarding Meicare payment policies for Part B drugs. Issues related to the 340B Drug discount program.

Lobbyist	Covered position, as disclosed
JODY SHINTARO GALE	—
JEFF MACKINNON	LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER	Prof Staff on E&C Cmte and LA Rep Whitfield
JOSEPH V VASAPOLI	Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.